Pirarubicin, actinomycin D, mitomycin, epirubicin hydrochloride, doxorubicin hydrochloride, pingyangmycin hydrochloride, daunorubicin hydrochloride, idarubicin hydrochloride and other anticancer pharmaceutical raw materials medicine
HS Code: 2941909091
SECTION 6
PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES
CHAPTER 29
Organic chemicals
HEADING 2941
Antibiotics;
HS Code Structure Breakdown
| Level | Code | Description |
|---|---|---|
| Section | 6 | PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES |
| Chapter | 29 | Organic chemicals |
| Heading | 2941 | Antibiotics; |
| Subheading | 294190 | Pirarubicin, actinomycin D, mitomycin, epirubicin hydrochloride, doxorubicin hydrochloride, pingyangmycin hydrochloride, daunorubicin hydrochloride, idarubicin hydrochloride and other anticancer pharmaceutical raw materials medicine |
| Commodity | 2941909091 | Pirarubicin, actinomycin D, mitomycin, epirubicin hydrochloride, doxorubicin hydrochloride, pingyangmycin hydrochloride, daunorubicin hydrochloride, idarubicin hydrochloride and other anticancer pharmaceutical raw materials medicine |
HS Code 2941909091 for Pirarubicin, actinomycin D, mitomycin, epirubicin hydrochloride, doxorubicin hydrochloride, pingyangmycin hydrochloride, daunorubicin hydrochloride, idarubicin hydrochloride and other anticancer pharmaceutical raw materials medicine
Product Wiki
Pirarubicin, actinomycin D, mitomycin, epirubicin hydrochloride, doxorubicin hydrochloride, pingyangmycin hydrochloride, daunorubicin hydrochloride, idarubicin hydrochloride and other anticancer pharmaceutical raw materials medicine has a clear classification code under the Harmonized Commodity Description and Coding System (HS Code), serving as an essential basis for customs authorities worldwide to conduct trade statistics and levy tariffs.
Cross-border trade data shows that China holds a non-negligible market share in the manufacturing and export supply of Pirarubicin, actinomycin D, mitomycin, epirubicin hydrochloride, doxorubicin hydrochloride, pingyangmycin hydrochloride, daunorubicin hydrochloride, idarubicin hydrochloride and other anticancer pharmaceutical raw materials medicine, with its export volume maintaining a high level over the long term.
Governments and industry associations worldwide usually set different market access standards, quality certifications, and environmental requirements for the import and export of Pirarubicin, actinomycin D, mitomycin, epirubicin hydrochloride, doxorubicin hydrochloride, pingyangmycin hydrochloride, daunorubicin hydrochloride, idarubicin hydrochloride and other anticancer pharmaceutical raw materials medicine.
With technological advancements and the diversification of market demands, the scope of application for Pirarubicin, actinomycin D, mitomycin, epirubicin hydrochloride, doxorubicin hydrochloride, pingyangmycin hydrochloride, daunorubicin hydrochloride, idarubicin hydrochloride and other anticancer pharmaceutical raw materials medicine continues to expand, driving the development of related industries.
Currently, the global supply-demand balance of Pirarubicin, actinomycin D, mitomycin, epirubicin hydrochloride, doxorubicin hydrochloride, pingyangmycin hydrochloride, daunorubicin hydrochloride, idarubicin hydrochloride and other anticancer pharmaceutical raw materials medicine is profoundly affected by macroeconomic fluctuations and geopolitics, with market prices and trade flows exhibiting cyclical variations.
Partner



Our licenses

China

HK MSO License

Singapore

UK API License

Netherlands

US MSB

CA MSB

AU RSP

